Background In many malignancies including ovarian cancer, different angiogenic factors
have been related to poor prognosis. However, data on their relations to each other or …

Objectives The identification of novel molecular biomarkers, predicting outcome of ovarian
cancer, is highly desirable. Considering that angiogenesis is a critical factor for ascites …

Background Peritoneal dissemination and retroperitoneal lymph node involvement are main
routes for progression of epithelial ovarian cancer (EOC). Vascular endothelial growth factor …

BACKGROUND The vascular endothelial growth factor (VEGF) family and VEGF receptors
(VEGFR) play an essential role in the angiogenesis of both pathologic and nonpathologic …

Purpose: Angiogenesis has a vital role in tumor growth and metastasis, and vascular
endothelial growth factor (VEGF) represents a potent cytokine in this process. However, the …

Purpose: To investigate the biological correlation between vascular endothelial growth
factor (VEGF)-C expression and invasive phenotype in ovarian carcinomas. Experimental …

Background Bevacizumab, which targets vascular endothelial growth factor (VEGF)-A, has
recently been proven to be effective for the treatment of epithelial ovarian cancer (EOC) …

Background The aim of the study was to explore the serum levels of eight angiogenesis
biomarkers in patients with benign, borderline or malignant epithelial ovarian neoplasms …

VEGF is an angiogenic factor with potent endothelial cell (EC) proliferative actions. Our aim
was to investigate whether expression of VEGF and its receptors and EC proliferation differ …

Purpose For patients with epithelial ovarian cancer (EOC) cytoreduction, with a combination
of taxane and platinum, is the standard of care. Despite this, approximately 50% of patients …